ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p1.xmlMeet the New JNCCN!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p1.pdf2026-04-18Meet the New JNCCN!https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pxxiv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pxxiv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pxiv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pxiv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p19.xmlIdentification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p19.pdf2026-04-18Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p9.xmlCotreatment of Hairy Cell Leukemia and Melanoma With the BRAF Inhibitor Dabrafenib2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p9.pdf2026-04-18Cotreatment of Hairy Cell Leukemia and Melanoma With the BRAF Inhibitor Dabrafenibhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p2.xmlAfter Local Therapy for Esophageal Cancer, Should We Continue to Survey Patients and, If So, Why and How?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p2.pdf2026-04-18After Local Therapy for Esophageal Cancer, Should We Continue to Survey Patients and, If So, Why and How?https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p7.xmlThe Birth of NCCN2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p7.pdf2026-04-18The Birth of NCCNhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p69.xmlGuideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p69.pdf2026-04-18Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p51.xmlPredictors of Guideline Treatment Nonadherence and the Impact on Survival in Patients With Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p51.pdf2026-04-18Predictors of Guideline Treatment Nonadherence and the Impact on Survival in Patients With Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p41.xmlEffect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Population2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p41.pdf2026-04-18Effect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Populationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p61.xmlCost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p61.pdf2026-04-18Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United Stateshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p78.xmlNeuroendocrine Tumors, Version 1.20152026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p78.pdf2026-04-18Neuroendocrine Tumors, Version 1.2015https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p23.xmlLung Cancer Screening, Version 1.20152026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p23.pdf2026-04-18Lung Cancer Screening, Version 1.2015https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pe1.xmlManagement of Chemotherapy-Induced Neutropenia: Measuring Quality, Cost, and Value2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-pe1.pdf2026-04-18Management of Chemotherapy-Induced Neutropenia: Measuring Quality, Cost, and Valuehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p109.xmlRole of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p109.pdf2026-04-18Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p118.xmlPaving the Road to Clinical Trial Participation: Removing Road Blocks and Directing Patients Toward Novel Therapies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/1/article-p118.pdf2026-04-18Paving the Road to Clinical Trial Participation: Removing Road Blocks and Directing Patients Toward Novel Therapies